We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




New Platform Prints Customized 3D Pharmaceuticals

By HospiMedica International staff writers
Posted on 20 Nov 2018
Print article
Image: A 3D printer in the lab of Professor Shlomo Magdassi (Photo courtesy of Hebrew University).
Image: A 3D printer in the lab of Professor Shlomo Magdassi (Photo courtesy of Hebrew University).
A novel technology platform uses three-dimensional (3D) printing to create custom drug capsules made of hydrogels with delayed release characteristics.

The new technology, developed at the Hebrew University (HUJI; Jerusalem, Israel), is designed to facilitate 3D printing of personalized medications out of hydrogels that can expand, change shape, and activate on a delayed schedule. By fine-tuning the drug capsules geometry, surface area, and swelling index, improved targeting of the site of drug release in the digestive tract is possible, as well as greater control of drug-release timing and duration.

The oral dosage forms of the pH responsive hydrogels were 3D printed using monomer acrylic acid, a polyethylene (glycol) diacrylate (PEGDA) cross-linker, and a thyroperoxidase (TPO) photoinitiator. The technology is based on photo-polymerization of photo-reactive compositions within a bath filled with a polymerizable ink, usually by ultraviolet (UV) digital light processing (DLP), which allows high resolution, complex structures, low printing cost, and large build size.

The printed structures can release drugs at a higher pH, enhancing drug absorption in the intestine. According to the researchers, the flexibility in design and manufacturing of the structures, the large surface area possible, and the complex geometries can be utilized for personalized, programmable delivery systems, with a variety of materials and functional properties that cannot be fabricated by conventional pharmaceutical manufacturing methods. The technology was presented at the 3D Printing and Beyond 2nd annual conference, held during November 2018 in Jerusalem (Israel).

“The custom-printed pills are made out of a hydrogel in which the medication is inserted. The substance has the consistency of malabi, a Middle Eastern milk pudding,” said Professor Shlomo Magdassi, PhD, head of the Hebrew University’s 3D and Functional Printing Center. “The technology enables the creation of pills with complex designs, from star-shaped to crystalline to round, that can expand, change shape and be activated on a preset schedule. This is currently not possible, or very expensive to do, in conventional pharmaceutical manufacturing techniques.”

“The flexibility enables the capsules to expand or release their medication at the location they need to target. For example, a tablet can be printed that can swell in the stomach to give a feeling of fullness, or to only release its medication in the intestine, where acidity is lower than in the stomach,” concluded Professor Magdassi. “These 3D printed objects will be able to change shape through contact with water, or humidity – enabling them to open only under certain conditions. It will also allow doctors to more specifically tailor the dosage of the drugs to individual patients.”

Related Links:
Hebrew University

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Silver Member
ECG Management System
NEMS-Q

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.